News

News from Tech Park Basel and its resident companies: research updates, company milestones and stories from our community.

News
TOLREMO therapeutics AG
15.09.26

TOLREMO therapeutics Completes Phase I Study of TT125-802

News
Tech Park Basel
09.09.26
After Work, Event, Internal Event

30.09. Lunch & Learn: Building High-Performing Startup Teams | 12.00 – 13.00h

News
BioVersys AG
22.04.26
News, Tenant News

BioVersys completes BV100 Phase 1 clinical trial in China

News
TOLREMO therapeutics AG
20.04.26
News, Tenant News

Stefanie Flückiger-Mangual from Tolremo therapeutics wins POWHER Award 2026

News
20.04.26
External News, News

Basel Incentive Programme entering the second round

News
14.04.26
News, Tenant News

BioVersys published data in Nature Communications

News
BioVersys AG
31.03.26
News, Tenant News

BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health

News
TOLREMO therapeutics AG
24.03.26
News, Tenant News

Stefanie Flückiger-Mangual, Founder & CEO of TOLREMO therapeutics, nominated for POWHER Emerging Entrepreneur 2026

News
Anaveon AG
24.03.26
News, Tenant News

Anaveon appoints Thaminda Ramanayake as Chief Executive Officer

News
BioVersys AG
16.03.26
News, Tenant News

BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start